RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.675
-0.115 (-2.40%)
At close: Jun 16, 2026, 4:00 PM EDT
4.680
+0.005 (0.11%)
After-hours: Jun 16, 2026, 5:26 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $193.53 million as of June 16, 2026. Its market cap has decreased by -69.33% in one year.
Market Cap
193.53M
Enterprise Value
-13.32M
1-Year Change
-69.33%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $193.53M, a decrease of -54.39%. That is a compound annual growth rate of -14.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 193.53M | -54.83% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 273.14M |
| TriSalus Life Sciences | 257.95M |
| Treace Medical Concepts | 254.30M |
| Profound Medical | 245.40M |
| Quantum-Si incorporated | 215.26M |
| Apyx Medical | 192.62M |
| Lucid Diagnostics | 190.77M |
| InfuSystem Holdings | 177.60M |